We serve Chemical Name:1-chloro-4-methylnaphthalene CAS:17075-39-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:1-chloro-4-methylnaphthalene
CAS.NO:17075-39-7
Synonyms:1-chloro-4-methyl-naphthalene;4-chloro-1-methylnaphthalene;4-Chlor-1-methylnaphthalin;Naphthalene,1-chloro-4-methyl;1-Chlor-4-methyl-naphthalin
Molecular Formula:C11H9Cl
Molecular Weight:176.64200
HS Code:2903999090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:281.9ºC at 760mmHg
Density:1.163g/cm3
Index of Refraction:1.627
PSA:
Exact Mass:176.03900
LogP:3.80160
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 1-chloro-4-methyl-naphthalene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-Chlor-4-methyl-naphthalin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Naphthalene,1-chloro-4-methyl Use and application,1-chloro-4-methyl-naphthalene technical grade,usp/ep/jp grade.
Related News: With rising demand and approvals required for new drugs, an external collaboration with CDMOs helps in driving a successful and robust clinical development plan for a new drug molecule. 4,4′,5,5′-tetrachloro-2,2′-dithiobis(benzoic acid) manufacturers Franco Stevanato, Giovanni’s 48-year-old grandson and the company’s executive chairman since stepping down as CEO in February, had his grandfather’s vision in mind when he virtually rang the opening bell on Wall Street on Tuesday. (+)-(6R,7S)-4-iodo-6,7-(isopropylidenedioxy)-5,6,7,8-tetrahydro-1-naphthol suppliers These sites operate under cGMP conditions and have been inspected and approved by leading global pharmaceutical companies and regulatory authorities, including the US FDA. 3α-acetoxyergosta-8(14),9(11),22-trien-7-one vendor & factory With rising demand and approvals required for new drugs, an external collaboration with CDMOs helps in driving a successful and robust clinical development plan for a new drug molecule. ,Grégoire then joined telecoms service provider Cirpack, following its acquisition of Andrexen, as Chief Marketing and Product Officer. He most recently held the position of Chief Strategy Officer at Experty.io, a blockchain-based knowledge sharing platform.
